Spots Global Cancer Trial Database for colon carcinoma
Every month we try and update this database with for colon carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery | NCT04955808 | Breast Carcinom... Colon Carcinoma Invasive Carcin... Kidney Carcinom... Liver Carcinoma Malignant Solid... Multiple Myelom... Prostate Carcin... | Biospecimen Col... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial) | NCT01696981 | Colon Carcinoma Rectal Carcinom... | Screening Quest... Sigmoidoscopy | 55 Years - 74 Years | National Cancer Institute (NCI) | |
| Safety and Feasibility of Immuno-OCT | NCT06008522 | Colon Carcinoma Barrett Esophag... Gastrointestina... | Bevacizumab-800... | 18 Years - | University Medical Center Groningen | |
| Clinical Outcomes for Offering Genetic Testing in a Tiered Approach | NCT04902144 | Breast Carcinom... Colon Carcinoma Malignant Solid... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... | Electronic Heal... Questionnaire A... Behavioral Inte... | 19 Years - 90 Years | Fred Hutchinson Cancer Center | |
| Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia | NCT01111292 | Colon Carcinoma Dysplasia in Cr... Low Grade Dyspl... Rectal Carcinom... | Inositol Placebo | 18 Years - | National Cancer Institute (NCI) | |
| Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer | NCT03408561 | Breast Carcinom... Colon Carcinoma Kidney Carcinom... Lymphoma Non-Small Cell ... Prostate Carcin... | Internet-Based ... Survey Administ... | - | University of Southern California | |
| Safety and Feasibility of Immuno-OCT | NCT06008522 | Colon Carcinoma Barrett Esophag... Gastrointestina... | Bevacizumab-800... | 18 Years - | University Medical Center Groningen | |
| Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy | NCT03631641 | Colon Adenoma Colon Carcinoma Lynch Syndrome MLH1 Gene Mutat... MSH2 Gene Mutat... | Nivolumab | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer | NCT03026140 | Colon Carcinoma | Nivolumab Ipilimumab Celecoxib 200mg BMS-986253 BMS-986016 | 18 Years - | The Netherlands Cancer Institute | |
| Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia | NCT01111292 | Colon Carcinoma Dysplasia in Cr... Low Grade Dyspl... Rectal Carcinom... | Inositol Placebo | 18 Years - | National Cancer Institute (NCI) | |
| Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery | NCT04955808 | Breast Carcinom... Colon Carcinoma Invasive Carcin... Kidney Carcinom... Liver Carcinoma Malignant Solid... Multiple Myelom... Prostate Carcin... | Biospecimen Col... Laboratory Biom... | 18 Years - | National Cancer Institute (NCI) | |
| Trained Immunity in Thyroid Carcinoma and Colon Carcinoma | NCT05280379 | Thyroid Cancer,... Colon Carcinoma | no intervention... | 18 Years - | Radboud University Medical Center | |
| Lymph Node Mapping Via Flourescent Dye in Colon Cancer | NCT04959604 | Colon Carcinoma Lymph Node Meta... | ICG-marking end... | 18 Years - 100 Years | Universitätsklinikum Hamburg-Eppendorf | |
| Safety and Feasibility of Immuno-OCT | NCT06008522 | Colon Carcinoma Barrett Esophag... Gastrointestina... | Bevacizumab-800... | 18 Years - | University Medical Center Groningen | |
| The Influence of Different Fluid Therapy Measures on the Postoperative Outcome in Fast Track of Colon Cancer.（FTSlapCC) | NCT02991092 | Colon Carcinoma | fluid administr... | 18 Years - 70 Years | The First Hospital of Jilin University | |
| Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer | NCT03026140 | Colon Carcinoma | Nivolumab Ipilimumab Celecoxib 200mg BMS-986253 BMS-986016 | 18 Years - | The Netherlands Cancer Institute | |
| The Influence of Different Fluid Therapy Measures on the Postoperative Outcome in Fast Track of Colon Cancer.（FTSlapCC) | NCT02991092 | Colon Carcinoma | fluid administr... | 18 Years - 70 Years | The First Hospital of Jilin University | |
| Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer | NCT01896778 | Adult Liver Car... Breast Carcinom... Colon Carcinoma Kidney Neoplasm Lung Carcinoma Malignant Head ... Malignant Neopl... Melanoma Ovarian Neoplas... Soft Tissue Sar... | Hyperthermia Tr... Laboratory Biom... | 18 Years - | Roswell Park Cancer Institute | |
| Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy | NCT03631641 | Colon Adenoma Colon Carcinoma Lynch Syndrome MLH1 Gene Mutat... MSH2 Gene Mutat... | Nivolumab | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients | NCT00473980 | Colorectal Canc... | Indomethacin, c... | 40 Years - 80 Years | Göteborg University | |
| Lymph Node Mapping Via Flourescent Dye in Colon Cancer | NCT04959604 | Colon Carcinoma Lymph Node Meta... | ICG-marking end... | 18 Years - 100 Years | Universitätsklinikum Hamburg-Eppendorf | |
| Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors | NCT05672342 | Breast Carcinom... Chemotherapy-In... Colon Carcinoma | Cannabidiol Delta-8-Tetrahy... Placebo Adminis... Questionnaire A... | 18 Years - | City of Hope Medical Center | |
| Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors | NCT05672342 | Breast Carcinom... Chemotherapy-In... Colon Carcinoma | Cannabidiol Delta-8-Tetrahy... Placebo Adminis... Questionnaire A... | 18 Years - | City of Hope Medical Center | |
| Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 | NCT02890758 | Acute Myeloid L... Myelodysplastic... Acute Lymphobla... Chronic Myeloid... Chronic Lymphoc... Non Hodgkin Lym... Hodgkin Lymphom... Myeloproliferat... Plasma Cell Mye... Colon Carcinoma Adenocarcinoma ... Soft Tissue Sar... Ewing's Sarcoma Rhabdomyosarcom... | Natural Killer ... ALT803 | 18 Years - | Case Comprehensive Cancer Center | |
| Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer | NCT03026140 | Colon Carcinoma | Nivolumab Ipilimumab Celecoxib 200mg BMS-986253 BMS-986016 | 18 Years - | The Netherlands Cancer Institute | |
| Trial for Retractor Sponge Evaluation in Laparoscopic Colorectal Surgery | NCT03334383 | Colon Carcinoma Rectum Carcinom... | Sponge | 18 Years - 95 Years | St. Antonius Hospital | |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) | NCT02465060 | Advanced Lympho... Advanced Malign... Bladder Carcino... Breast Carcinom... Cervical Carcin... Colon Carcinoma Colorectal Carc... Endometrial Car... Esophageal Carc... Gastric Carcino... Glioma Head and Neck C... Hematopoietic a... Kidney Carcinom... Liver Carcinoma Lung Carcinoma Lymphoma Malignant Uteri... Melanoma Multiple Myelom... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... Rectal Carcinom... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Color... Recurrent Esoph... Recurrent Gastr... Recurrent Gliom... Recurrent Head ... Recurrent Liver... Recurrent Lung ... Recurrent Lymph... Recurrent Malig... Recurrent Melan... Recurrent Multi... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Skin ... Recurrent Thyro... Recurrent Uteri... Refractory Lymp... Refractory Mali... Refractory Mult... Skin Carcinoma Thyroid Gland C... Uterine Corpus ... | Adavosertib Afatinib Afatinib Dimale... Binimetinib Biopsy Biospecimen Col... Capivasertib Computed Tomogr... Copanlisib Copanlisib Hydr... Crizotinib Cytology Specim... Dabrafenib Dabrafenib Mesy... Dasatinib Defactinib Defactinib Hydr... Echocardiograph... Erdafitinib Fexagratinib Ipatasertib Laboratory Biom... Larotrectinib Larotrectinib S... Magnetic Resona... Multigated Acqu... Nivolumab Osimertinib Palbociclib Pertuzumab PI3K-beta Inhib... Radiologic Exam... Radionuclide Im... Relatlimab Sapanisertib Sunitinib Malat... Taselisib Trametinib Trastuzumab Trastuzumab Emt... Ulixertinib Vismodegib | 18 Years - | National Cancer Institute (NCI) | |
| A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making | NCT00122135 | Congestive Hear... Chronic Obstruc... Cirrhosis Colon Carcinoma Lung Cancer Chronic Kidney ... | Values Inventor... | 55 Years - | VA Office of Research and Development | |
| L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases | NCT01462513 | Colon Carcinoma Rectum Carcinom... | L-BLP25 Placebo | 18 Years - 120 Years | Johannes Gutenberg University Mainz | |
| Lymph Node Mapping Via Flourescent Dye in Colon Cancer | NCT04959604 | Colon Carcinoma Lymph Node Meta... | ICG-marking end... | 18 Years - 100 Years | Universitätsklinikum Hamburg-Eppendorf | |
| Characterization of Mechanical Tissue Properties in Patients With Pancreatic, Liver, or Colon Cancer | NCT03137706 | Colon Carcinoma Liver and Intra... Pancreatic Carc... | Biospecimen Col... Laboratory Biom... Laboratory Proc... | 18 Years - | University of Southern California | |
| L-BLP25 in Patients With Colorectal Carcinoma After Curative Resection of Hepatic Metastases | NCT01462513 | Colon Carcinoma Rectum Carcinom... | L-BLP25 Placebo | 18 Years - 120 Years | Johannes Gutenberg University Mainz | |
| Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial) | NCT01696981 | Colon Carcinoma Rectal Carcinom... | Screening Quest... Sigmoidoscopy | 55 Years - 74 Years | National Cancer Institute (NCI) | |
| Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients | NCT00473980 | Colorectal Canc... | Indomethacin, c... | 40 Years - 80 Years | Göteborg University | |
| Role of Immunoscore® in Stage II-III Colorectal Cancer | NCT05422547 | Colon Adenocarc... | Immunoscore Col... | - | D'Or Institute for Research and Education | |
| A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | NCT00753415 | Non-Small Cell ... Breast Cancer Melanoma Upper GI Tract ... Colon Carcinoma Renal Cell Carc... Bladder Carcino... Prostate Cancer | V935 V934-EP | 18 Years - | Merck Sharp & Dohme LLC | |
| Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues | NCT04147494 | Breast Carcinom... Colon Carcinoma Esophageal Carc... Gastric Carcino... Head and Neck C... Kidney Carcinom... Lung Carcinoma Ovarian Carcino... Pancreatic Carc... Solid Neoplasm Uterine Corpus ... | Computed Tomogr... Gallium Ga 68 F... Gallium Ga 68-l... Positron Emissi... 18F-FDG | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver | NCT00149396 | Colorectal Canc... Liver Neoplasms | NV1020 | 18 Years - | MediGene | |
| Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial) | NCT01696981 | Colon Carcinoma Rectal Carcinom... | Screening Quest... Sigmoidoscopy | 55 Years - 74 Years | National Cancer Institute (NCI) | |
| Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer | NCT03408561 | Breast Carcinom... Colon Carcinoma Kidney Carcinom... Lymphoma Non-Small Cell ... Prostate Carcin... | Internet-Based ... Survey Administ... | - | University of Southern California | |
| Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer | NCT04505553 | Appendix Carcin... Colon Carcinoma Esophageal Carc... Gastric Carcino... Liver and Intra... Malignant Diges... Pancreatic Carc... Rectal Carcinom... Small Intestina... Anal Carcinoma Digestive Syste... Digestive Syste... Pancreatic Neur... | Acupuncture The... Acupressure The... Oral Cryotherap... Questionnaire A... Quality-of-Life... | 18 Years - | University of Washington | |
| Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver | NCT00149396 | Colorectal Canc... Liver Neoplasms | NV1020 | 18 Years - | MediGene | |
| Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients | NCT00473980 | Colorectal Canc... | Indomethacin, c... | 40 Years - 80 Years | Göteborg University | |
| Clinical Outcomes for Offering Genetic Testing in a Tiered Approach | NCT04902144 | Breast Carcinom... Colon Carcinoma Malignant Solid... Ovarian Carcino... Pancreatic Carc... Prostate Carcin... | Electronic Heal... Questionnaire A... Behavioral Inte... | 19 Years - 90 Years | Fred Hutchinson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
